David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 10.34% |
| 2 | Technology | 9.79% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Healthcare | 8.68% |
| 5 | Financials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SN
2751
CALL
DELISTED
Sanchez Energy Corporation
SN
| $748K | ﹤0.01% |
57,500
-30,000
| -34% | -$366K |
|
2752
PUT
AngloGold Ashanti
AU
$59.7B
| $747K | ﹤0.01% |
80,000
-73,900
| -48% | -$791K |
|
|
PGTI
2753
DELISTED
PGT, Inc.
PGTI
| $747K | ﹤0.01% |
+66,862
| New | +$648K |
|
|
CAS
2754
DELISTED
A M Castle & Co
CAS
| $747K | ﹤0.01% |
204,710
+23,241
| +13% | +$119K |
|
2755
SiriusPoint
SPNT
$2.79B
| $746K | ﹤0.01% |
+52,753
| New | +$732K |
|
|
MFLX
2756
DELISTED
MULTI-FINELINE ELECTRONIX INC
MFLX
| $746K | ﹤0.01% |
40,853
+4,436
| +12% | +$69.6K |
|
2757
Culp Inc
CULP
$43.6M
| $744K | ﹤0.01% |
27,803
+72
| +0.3% | +$1.63K |
|
|
SNOW
2758
DELISTED
Intrawest Resorts Holdings, Inc.
SNOW
| $744K | ﹤0.01% |
85,278
+9,916
| +13% | +$97K |
|
|
CLVS
2759
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
| $742K | ﹤0.01% |
+10,000
| New | +$706K |
|
|
BGC
2760
DELISTED
General Cable Corporation
BGC
| $741K | ﹤0.01% |
43,033
-141,949
| -77% | -$2.01M |
|
|
IMPR
2761
DELISTED
IMPRIVATA, INC COM
IMPR
| $741K | ﹤0.01% |
52,917
+23,045
| +77% | +$318K |
|
2762
Fulton Financial
FULT
$4.54B
| $739K | ﹤0.01% |
+59,876
| New | +$717K |
|
2763
Asbury Automotive
ABG
$3.77B
| $735K | ﹤0.01% |
+8,840
| New | +$682K |
|
2764
Artivion
AORT
$1.33B
| $734K | ﹤0.01% |
70,803
+4,861
| +7% | +$53.6K |
|
2765
CALL
US Bancorp
USB
$97.8B
| $734K | ﹤0.01% |
16,800
-384,900
| -96% | -$16.9M |
|
|
MSB
2766
Mesabi Trust
MSB
$303M
| $733K | ﹤0.01% |
54,998
-13,346
| -20% | -$229K |
|
2767
BorgWarner
BWA
$13.2B
| $730K | ﹤0.01% |
13,714
-415,452
| -97% | -$21.2M |
|
2768
CALL
Ventas
VTR
$48B
| $730K | ﹤0.01% |
+8,757
| New | +$754K |
|
|
AMPE
2769
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $730K | ﹤0.01% |
323
+25
| +8% | +$42.6K |
|
2770
CALL
Deckers Outdoor
DECK
$12.2B
| $729K | ﹤0.01% |
60,000
-267,000
| -82% | -$3.43M |
|
|
2771
PUT
Deckers Outdoor
DECK
$12.2B
| $729K | ﹤0.01% |
+60,000
| New | +$771K |
|
2772
CALL
Eli Lilly
LLY
$1.06T
| $727K | ﹤0.01% |
10,000
-71,400
| -88% | -$5.08M |
|
|
FWM
2773
DELISTED
FAIRWAY GROUP HLDGS CORP CL A COM STK (DE)
FWM
| $727K | ﹤0.01% |
107,400
+7,141
| +7% | +$35.7K |
|
2774
Agios Pharmaceuticals
AGIO
$2.03B
| $726K | ﹤0.01% |
+7,696
| New | +$862K |
|
2775
Canadian Solar
CSIQ
$942M
| $726K | ﹤0.01% |
21,748
-250,084
| -92% | -$6.9M |
|
Similar funds
David Shaw's Q1 2015 Portfolio in Review
As of Q1 2015, David Shaw held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $15B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 10% of assets, up from 8.6% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in SPDR Gold Trust worth $231M.
- David Shaw's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- David Shaw's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- David Shaw fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- David Shaw's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- David Shaw opened 448 new positions and closed 828 in Q1 2015.
- David Shaw's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.